2017-03-20,Bluebird Bio Appoints New Senior Manufacturing And Corporate Development Executives
2017-03-01,Bluebird Bio Announces Publication Of Case Study On First Patient With Severe Sickle Cell Disease Treated With Gene Therapy In The New England Journal Of Medicine
2017-02-28,Bluebird Bio To Present At Two Investor Conferences In March
2017-02-24,5 Stocks Set for Explosive Breakouts
2017-02-22,Bluebird Bio Reports Fourth Quarter And Full Year 2016 Financial Results And Recent Operational Progress
2017-02-15,Watching for More Movement in Bluebird BIO and 3 Others
2017-02-06,Biotech Premarket Movers: Cytokinetics, Artana Therapeutics, Bluebird
2017-02-03,Bluebird Bio Announces First Patient Treated With LentiGlobinTM Drug Product Under Amended Study Protocol In HGB-206 Phase 1 Study Of Patients With Severe Sickle Cell Disease
2017-01-31,Unlike Silicon Valley, Biopharma's Top Execs React to Trump Migration Ban With Universal Silence
2017-01-31,Bluebird Bio Looks Set to Soar Upward
2017-01-04,Bluebird Bio To Present At The 35th Annual J.P. Morgan Healthcare Conference
2016-12-28,Short Interest In Bluebird Bio Moves 11.2% Lower
2016-12-23,'Mad Money' Lightning Round: Southwestern Energy, UnitedHealth, Celgene and More
2016-12-22,Jim Cramer's 'Mad Money' Recap: Don't Worry About a Little Market Detour
2016-12-15,Bluebird Bio And Apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement
2016-12-14,Bluebird Bio Announces First Patient Treated With LentiGlobinTM Drug Product In Northstar-2 (HGB-207) Phase 3 Trial Of Patients With Transfusion-Dependent ß-Thalassemia
2016-12-07,Biotech Only Sector in the Red as Trump Vows to Crackdown on Drug Pricing, Biggest Movers
2016-12-07,Dow Scores Another Record for Third Consecutive Day; S&amp;P 500 Also Hits New High
2016-12-07,Dow, S&amp;P 500 Trade at Session Highs in Broad Wall Street Rally
2016-12-07,S&amp;P 500 and Dow Reverse Losses to Post Intraday Records
2016-12-07,Trump's Drug Pricing Comment Sends Biotech Stocks Into Free-Fall
2016-12-06,Bluebird Bio Announces Pricing Of Public Offering Of Common Stock
2016-12-06,Bluebird Bio Announces Proposed Public Offering Of Common Stock
2016-12-05,Bluebird Bio Provides Updates On HSC Gene Therapy Programs
2016-12-05,Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
2016-12-03,Bluebird Bio Presents New Data From HGB-205 Study Of LentiGlobinTM Drug Product In Patients With Transfusion-Dependent ß-Thalassemia (TDT) And Severe Sickle Cell Disease At American Society Of Hematology (ASH) Annual Meeting
2016-12-02,Bluebird Bio Announces Management Appointments
2016-12-01,Jim Cramer's 'Mad Money' Recap: This Rotation's Too Hard for the Bulls
2016-12-01,Oil Prices Keep Rising on OPEC Deal; Bluebird, Celgene T-Cell Therapy Sees Success
2016-11-30,Bluebird Bio Announces Interim Phase 1 Dose Escalation Data For Its Anti-BCMA CAR T Product Candidate In Patients With Relapsed/Refractory Multiple Myeloma
2016-11-30,Bluebird, Celgene T-Cell Therapy Eliminates Multiple Myeloma With Minimal Side Effects
2016-11-19,How Buying Blue Apron Ahead of any IPO Could Leave You Blue
2016-11-14,Bluebird Bio To Present New Data From Novel Anti-BCMA CAR T Cell Therapy Bb2121 At EORTC-NCI-AACR Molecular Targets And Cancer Therapies Symposium
2016-11-03,The Great 'ASH16' Abstract Drop Mostly Causes Drug Stocks to Do Same
2016-11-03,Bluebird Bio To Present New Data From Three LentiGlobinTM Clinical Studies At American Society Of Hematology (ASH) Annual Meeting
2016-11-02,Bluebird Bio Reports Third Quarter 2016 Financial Results And Recent Operational Progress
2016-11-01,Bluebird Bio To Present At Two Investor Conferences In November
2016-10-18,Why Celgene Is a Core Biotech Holding
2016-10-17,Trader's Daily Notebook: You Might Consider Selling Facebook
2016-10-14,Bluebird Bio Shares End Friday's Session Down 13%
2016-10-13,Bluebird Bio Provides Update On LentiGlobin™ Programs And Research And Development Strategy At Gene Therapy Day
2016-10-06,Bluebird Bio Announces Topics For Gene Therapy Day, October Investor Presentation
2016-09-30,Buy These 4 Stocks and Beat Biotech's Slump
2016-09-29,Bluebird Bio And Medigene Establish Strategic T Cell Receptor (TCR) Alliance In Cancer Immunotherapy
2016-09-28,Four Stellar Stocks to Beat the Biotech Slump
2016-09-26,OPEC, HP, Ulta Salon and Lululemon: Jim Cramer's Views
2016-09-24,'Mad Money' Lightning Round: Buy, Buy, Buy Advanced Micro Devices
2016-09-23,Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
2016-09-21,LentiGlobin™ Investigational Gene Therapy For Transfusion-Dependent Beta-Thalassemia Accepted Into European Medicines Agency's PRIME Program
2016-09-15,Bluebird Bio (BLUE) Stock Jumping, Goldman Adds to Conviction Buy List
2016-09-14,Here's a Reason Why Bluebird Bio (BLUE) Stock Is Jumping Today
2016-09-09,Bluebird Bio Announces Webcast Of Gene Therapy Day
2016-09-08,Bluebird Improves Its Gene Therapy, Removing an Investor Concern
2016-09-08,Bluebird Bio Opens Phase 3 Study Of LentiGlobin™ Drug Product In Patients With Transfusion-Dependent Beta-Thalassemia
2016-09-07,Oncorus®, Inc. Appoints Biotech Industry Veteran Cyrus D. Mozayeni, M.D., As President And Chief Business Officer
2016-08-30,Bluebird Bio To Present At Four Upcoming Conferences
2016-08-05,Trade-Ideas: Bluebird Bio (BLUE) Is Today's "Dead Cat Bounce" Stock
2016-08-04,Bluebird Bio (BLUE) In A Perilous Reversal
2016-08-04,Bluebird Bio To Present At Wedbush PacGrow Healthcare Conference
2016-08-03,Bluebird Bio Reports Second Quarter 2016 Financial Results And Recent Operational Progress
2016-08-01,Bluebird Bio (BLUE) Weak On High Volume
2016-07-28,4 Stocks to Play In Today's Market
2016-07-27,Bluebird Bio (BLUE) Marked As A Barbarian At The Gate
2016-07-22,Insider Trading Alert - AA, BLUE And VLGEA Traded By Insiders
2016-07-19,Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development Pact
2016-07-18,Bluebird Bio Presents MegaTAL Genome Editing Data At American Society Of Hematology (ASH) Workshop On Genome Editing
2016-07-07,Juno Patient Deaths Crash Cancer-Killing CAR-T Party
2016-07-01,Biotech Stock Mailbag: Mid-Year Assessment, Where We Go From Here
2016-06-27,A Biotech Stock Turnaround Requires an Alzheimer's Drug Miracle
2016-06-18,These 5 Stocks Could Be Toxic to Your Portfolio
2016-06-10,Global Blood Shows Extended, Safe Treatment Effect for Sickle Cell Disease Drug
2016-06-06,Bluebird Bio (BLUE) Is Today's Dead Cat Bounce Stock
2016-06-03,Stock To Watch: Bluebird Bio (BLUE) In Perilous Reversal
2016-05-23,Bluebird Bio To Present At Goldman Sachs 37th Annual Healthcare Conference
2016-05-13,Bluebird Bio (BLUE) Showing Signs Of A Dead Cat Bounce Today
2016-05-12,Mast Sickle Cell Drug Seeks to Defy Long Odds Like Leicester City
2016-05-10,Trade-Ideas: Bluebird Bio (BLUE) Is Today's "Perilous Reversal" Stock
2016-05-09,Bluebird Bio Presents Oncology And Gene Therapy Data At The ASGCT 19th Annual Meeting
2016-05-04,Bluebird Bio Reports First Quarter 2016 Financial Results And Recent Operational Progress
2016-04-27,Bluebird Bio To Present At Two Upcoming Investor Conferences
2016-04-20,Weak On High Volume: Bluebird Bio (BLUE)
2016-04-20,Bluebird Bio Reports Interim Clinical Data From Starbeam Study Of Lenti-D™ At AAN 2016 Annual Meeting
2016-04-20,Bluebird Bio Gene Therapy Shows Early Promise in Fatal Childhood Brain Disease
2016-04-18,Bluebird Bio To Present Immuno-Oncology And Gene Therapy Data At The ASGCT 19th Annual Meeting
2016-03-10,Bluebird Bio (BLUE) Is Today's Dead Cat Bounce Stock
2016-03-09,Today's Weak On High Volume Stock: Bluebird Bio (BLUE)
2016-03-03,Bluebird Bio To Present Clinical Data On Lenti-D In CALD In Plenary Session At AAN 2016 Annual Meeting
2016-03-02,Bluebird Bio To Present At Three Upcoming Investor Conferences
2016-02-26,Bluebird Bio (BLUE) Is Today's Dead Cat Bounce Stock
2016-02-25,Bluebird Bio Announces Transition Of Chief Financial Officer
2016-02-24,Bluebird Bio Reports Fourth Quarter And Full Year 2015 Financial Results And Recent Operational Progress
2016-02-17,Bluebird Bio Announces First Patient Treated With Bb2121 In CRB-401 Phase 1 Study In Patients With Relapsed/Refractory Multiple Myeloma
2016-02-02,Perilous Reversal Watch: Bluebird Bio (BLUE)
2016-01-29,Trade-Ideas: Bluebird Bio (BLUE) Is Today's "Dead Cat Bounce" Stock
2016-01-20,Commit To Buy bluebird bio At $22.50, Earn 20.4% Using Options
2016-01-13,bluebird bio (BLUE) Showing Signs of Perilous Reversal Today
2016-01-12,Bluebird Bio (BLUE) Is Today's Dead Cat Bounce Stock
2016-01-11,A Lack of News and Buzz at 'JPM16' Sinks Biotech Stocks
2016-01-11,Water-Logged And Getting Wetter Stock Of The Day: Bluebird Bio (BLUE)
2016-01-09,2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
2016-01-05,Bluebird Bio To Present At The 34th Annual J.P. Morgan Healthcare Conference
2016-01-01,Feuerstein's Heroes and Zeroes of Biotech Investing in 2015
2015-12-08,2 'Rules of the Road' for Biotech Investing
2015-12-07,Stocks Slump as Oil Closes at Lowest Since 2009
2015-12-07,Bluebird Bio Crashes After ASH Meeting Followed By Downgrades
2015-12-07,Midday Report: Keurig Deal Boosts Peers; Energy Stocks Slump
2015-12-07,Stocks Plummet as Crude Oil Nears $38
2015-12-07,Bluebird Bio (BLUE) Stock Tanks Following Analyst Downgrade
2015-12-07,Stock Futures Turn Mixed as Keurig Jumps, Chipotle Slumps
2015-12-07,Analysts' Actions -- Big Lots, Bluebird Bio, Eli Lilly, Match Group and More
2015-12-07,Bluebird Bio (BLUE): Heavy Pre-Market Activity
2015-12-07,Investors Remain Skeptical about Bluebird Gene Therapy for Blood Disease
2015-12-06,Bluebird Bio Presents Pre-Clinical And Manufacturing Data From CAR T Oncology Programs At ASH Annual Meeting
2015-12-06,Bluebird Sickle Cell Gene Therapy Falls Short of High Expectations
2015-12-06,Bluebird Bio Reports New Beta-thalassemia Major And Severe Sickle Cell Disease Data From HGB-205 And HGB-206 Studies Of LentiGlobin® At ASH Annual Meeting
2015-12-05,Bluebird, Celgene See Promise in T Cell Therapy for Multiple Myeloma
2015-12-05,Bluebird Bio Reports New Beta-thalassemia Major Data From Northstar Study Of LentiGlobin® At ASH Annual Meeting
2015-12-03,Bluebird Bio And ViroMed Enter Into License Agreement For Novel Antibodies To Develop Chimeric Antigen Receptor T Cell Therapy
2015-12-02,Bluebird Bio (BLUE) Marked As A Dead Cat Bounce Stock
2015-12-01,Jim Cramer's 'Mad Money' Recap: Stocks Gain When Analysts Curb Negativity
2015-11-25,Bluebird Bio Announces Participation In 27th Annual Piper Jaffray Healthcare Conference
2015-11-22,Goldman Sachs Says These 12 Small-Cap Stocks Are Worth Buying
2015-11-21,Clovis Blowup Conjures Bad Biotech Memories of ImClone Darkness
2015-11-19,Perilous Reversal Stock: Bluebird Bio (BLUE)
2015-11-18,Goldman Sees Bluebird Shares Doubling On 'One-Shot' Gene Therapy
2015-11-18,Today's Pre-Market Trading Very Positive For Bluebird Bio (BLUE)
2015-11-13,Biotech Stock Mailbag: Relypsa, Sophiris, Bluebird, Zafgen, NW Bio
2015-11-06,Bluebird Bio (BLUE) Marked As A Dead Cat Bounce Stock
2015-11-05,Bluebird Bio (BLUE): Heavy Pre-Market Activity
2015-11-05,Bluebird Gene Therapy Narrative Shift: 'Cure' May Elude Some Patients
2015-11-05,Bluebird Bio To Present LentiGlobin® BB305 Clinical Data And Bb2121 Preclinical Data At Annual Meeting Of The American Society Of Hematology
2015-11-04,Bluebird Bio Reports Third Quarter 2015 Financial Results And Recent Operational Progress
2015-11-04,Bluebird Bio Announces Participation In 24th Annual Credit Suisse Healthcare Conference
2015-10-23,Trade-Ideas: Bluebird Bio (BLUE) Is Today's Strong On High Relative Volume Stock
2015-10-19,Bluebird Shares Plunge on Waning Effect of Old Gene Therapy
2015-10-19,Bluebird Bio (BLUE) Showing Signs Of Being Water-Logged And Getting Wetter
2015-10-19,Bluebird Bio Announces Presentation At Cooley's Anemia Foundation Symposium
2015-10-16,Trade-Ideas: Bluebird Bio (BLUE) Is Today's Strong On High Relative Volume Stock
2015-10-16,Biotech Stock Mailbag: New Sarepta Risk, Zafgen Patient Death, Bluebird Gene Therapy Update
2015-10-07,Jim Cramer -- Microsoft, General Mills, WhiteWave Are Buying Opportunities
2015-10-07,Jim Cramer Bullish on Microsoft, Likes General Mills and WhiteWave
2015-10-05,Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector
2015-10-05,Trade-Ideas: Bluebird Bio (BLUE) Is Today's Pre-Market Leader Stock
2015-10-05,Analysts' Actions -- Twitter, AutoZone, Tyco, Viacom
2015-10-02,5 Stocks Poised for Breakouts
2015-09-29,Strong On High Volume: Bluebird Bio (BLUE)
2015-09-29,Alexandria Real Estate Equities, Inc. Announces 10-Year 253,000 RSF Full-Building Build-to-Suit Lease At 60 Binney Street For Bluebird Bio For Its New Office/Laboratory Headquarters In The Heart Of Kendall Square In Cambridge, MA
2015-09-25,bluebird bio is Now Oversold
2015-09-25,Biotech Stock Mailbag: Rebounding From Hillary's Drug Tweet; Global Blood Weighs on Bluebird
2015-09-24,Bluebird Bio Announces Participation In Leerink Partners Immuno-Oncology Roundtable
2015-09-21,Bluebird Bio (BLUE) Is Water-Logged And Getting Wetter Today
2015-09-11,Bluebird Bio Announces Participation At Morgan Stanley Global Healthcare Conference
2015-09-09,Perilous Reversal Watch: Bluebird Bio (BLUE)
2015-09-04,2 Issues Keeping Buyers on the Sidelines Today
2015-09-01,The Numbers Behind Biotech's Horrible, No Good, Awful August
2015-08-26,Biotech Selloff Has No Effect on Cellectis Advances: CEO
2015-08-26,Biotech Selloff Does Not Dim Immunotherapy Advances Says Cellectis CEO
2015-08-21,Biotech Stock Mailbag: Celldex, Bluebird, Kite, Inovio
2015-08-19,Biotech Stocks Get Burned This Summer, but Fall Might Bring Relief
2015-08-12,Bluebird, Pacira Pharmaceuticals Excite Life Science Investors
2015-08-12,Bluebird, Pacira Pharmaceuticals Gain Steam in Burgeoning Life Science Space
2015-08-10,BLUE, TEVA And AMGN, 3 Drugs Stocks Pushing The Industry Lower
2015-08-07,Water-Logged And Getting Wetter: Bluebird Bio (BLUE)
2015-08-06,Bluebird Bio Reports Second Quarter 2015 Financial Results And Recent Operational Progress
2015-08-05,Trade-Ideas: Bluebird Bio (BLUE) Is Today's Post-Market Leader Stock
2015-08-05,Bluebird Bio Announces Participation At The 2015 Wedbush PacGrow Healthcare Conference
2015-07-27,Biogen's Possible Takeout Targets and Other Key Questions After Blow-Up
2015-07-02,Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point
2015-07-01,Today's Perilous Reversal Stock: Bluebird Bio (BLUE)
2015-06-30,Today's Top Performers In Health Care
2015-06-30,Celgene on My Shopping List for a Pullback
2015-06-29,Celgene is Desperate or Insane to Pay Ultra-High Premium for Juno Partnership
2015-06-29,Trade-Ideas: Bluebird Bio (BLUE) Is Today's Post-Market Leader Stock
2015-06-23,Bluebird Bio Announces Pricing Of Public Offering Of Common Stock
2015-06-23,Bluebird Bio Announces Proposed Public Offering Of Common Stock
2015-06-19,Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!
2015-06-19,'Mad Money' Lightning Round: Buy, Buy, Buy Citigroup
2015-06-18,Jim Cramer's 'Mad Money' Recap: Here's Why We Had a Rally Today
2015-06-16,Avalanche Fails Common-Sense Test, Kicked Out of Gene Therapy Credibility Club
2015-06-15,Philip Gregory, D. Phil., Joins Bluebird Bio As Chief Scientific Officer
2017-03-20,Bluebird Bio Appoints New Senior Manufacturing And Corporate Development Executives
2017-03-01,Bluebird Bio Announces Publication Of Case Study On First Patient With Severe Sickle Cell Disease Treated With Gene Therapy In The New England Journal Of Medicine
2017-02-28,Bluebird Bio To Present At Two Investor Conferences In March
2017-02-24,5 Stocks Set for Explosive Breakouts
2017-02-22,Bluebird Bio Reports Fourth Quarter And Full Year 2016 Financial Results And Recent Operational Progress
2017-02-15,Watching for More Movement in Bluebird BIO and 3 Others
2017-02-06,Biotech Premarket Movers: Cytokinetics, Artana Therapeutics, Bluebird
2017-02-03,Bluebird Bio Announces First Patient Treated With LentiGlobinTM Drug Product Under Amended Study Protocol In HGB-206 Phase 1 Study Of Patients With Severe Sickle Cell Disease
2017-01-31,Unlike Silicon Valley, Biopharma's Top Execs React to Trump Migration Ban With Universal Silence
2017-01-31,Bluebird Bio Looks Set to Soar Upward
2017-01-04,Bluebird Bio To Present At The 35th Annual J.P. Morgan Healthcare Conference
2016-12-28,Short Interest In Bluebird Bio Moves 11.2% Lower
2016-12-23,'Mad Money' Lightning Round: Southwestern Energy, UnitedHealth, Celgene and More
2016-12-22,Jim Cramer's 'Mad Money' Recap: Don't Worry About a Little Market Detour
2016-12-15,Bluebird Bio And Apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement
2016-12-14,Bluebird Bio Announces First Patient Treated With LentiGlobinTM Drug Product In Northstar-2 (HGB-207) Phase 3 Trial Of Patients With Transfusion-Dependent ß-Thalassemia
2016-12-07,Biotech Only Sector in the Red as Trump Vows to Crackdown on Drug Pricing, Biggest Movers
2016-12-07,Dow Scores Another Record for Third Consecutive Day; S&amp;P 500 Also Hits New High
2016-12-07,Dow, S&amp;P 500 Trade at Session Highs in Broad Wall Street Rally
2016-12-07,S&amp;P 500 and Dow Reverse Losses to Post Intraday Records
2016-12-07,Trump's Drug Pricing Comment Sends Biotech Stocks Into Free-Fall
2016-12-06,Bluebird Bio Announces Pricing Of Public Offering Of Common Stock
2016-12-06,Bluebird Bio Announces Proposed Public Offering Of Common Stock
2016-12-05,Bluebird Bio Provides Updates On HSC Gene Therapy Programs
2016-12-05,Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
2016-12-03,Bluebird Bio Presents New Data From HGB-205 Study Of LentiGlobinTM Drug Product In Patients With Transfusion-Dependent ß-Thalassemia (TDT) And Severe Sickle Cell Disease At American Society Of Hematology (ASH) Annual Meeting
2016-12-02,Bluebird Bio Announces Management Appointments
2016-12-01,Jim Cramer's 'Mad Money' Recap: This Rotation's Too Hard for the Bulls
2016-12-01,Oil Prices Keep Rising on OPEC Deal; Bluebird, Celgene T-Cell Therapy Sees Success
2016-11-30,Bluebird Bio Announces Interim Phase 1 Dose Escalation Data For Its Anti-BCMA CAR T Product Candidate In Patients With Relapsed/Refractory Multiple Myeloma
2016-11-30,Bluebird, Celgene T-Cell Therapy Eliminates Multiple Myeloma With Minimal Side Effects
2016-11-19,How Buying Blue Apron Ahead of any IPO Could Leave You Blue
2016-11-14,Bluebird Bio To Present New Data From Novel Anti-BCMA CAR T Cell Therapy Bb2121 At EORTC-NCI-AACR Molecular Targets And Cancer Therapies Symposium
2016-11-03,The Great 'ASH16' Abstract Drop Mostly Causes Drug Stocks to Do Same
2016-11-03,Bluebird Bio To Present New Data From Three LentiGlobinTM Clinical Studies At American Society Of Hematology (ASH) Annual Meeting
2016-11-02,Bluebird Bio Reports Third Quarter 2016 Financial Results And Recent Operational Progress
2016-11-01,Bluebird Bio To Present At Two Investor Conferences In November
2016-10-18,Why Celgene Is a Core Biotech Holding
2016-10-17,Trader's Daily Notebook: You Might Consider Selling Facebook
2016-10-14,Bluebird Bio Shares End Friday's Session Down 13%
2016-10-13,Bluebird Bio Provides Update On LentiGlobin™ Programs And Research And Development Strategy At Gene Therapy Day
2016-10-06,Bluebird Bio Announces Topics For Gene Therapy Day, October Investor Presentation
2016-09-30,Buy These 4 Stocks and Beat Biotech's Slump
2016-09-29,Bluebird Bio And Medigene Establish Strategic T Cell Receptor (TCR) Alliance In Cancer Immunotherapy
2016-09-28,Four Stellar Stocks to Beat the Biotech Slump
2016-09-26,OPEC, HP, Ulta Salon and Lululemon: Jim Cramer's Views
2016-09-24,'Mad Money' Lightning Round: Buy, Buy, Buy Advanced Micro Devices
2016-09-23,Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
2016-09-21,LentiGlobin™ Investigational Gene Therapy For Transfusion-Dependent Beta-Thalassemia Accepted Into European Medicines Agency's PRIME Program
2016-09-15,Bluebird Bio (BLUE) Stock Jumping, Goldman Adds to Conviction Buy List
2016-09-14,Here's a Reason Why Bluebird Bio (BLUE) Stock Is Jumping Today
2016-09-09,Bluebird Bio Announces Webcast Of Gene Therapy Day
2016-09-08,Bluebird Improves Its Gene Therapy, Removing an Investor Concern
2016-09-08,Bluebird Bio Opens Phase 3 Study Of LentiGlobin™ Drug Product In Patients With Transfusion-Dependent Beta-Thalassemia
2016-09-07,Oncorus®, Inc. Appoints Biotech Industry Veteran Cyrus D. Mozayeni, M.D., As President And Chief Business Officer
2016-08-30,Bluebird Bio To Present At Four Upcoming Conferences
2016-08-05,Trade-Ideas: Bluebird Bio (BLUE) Is Today's "Dead Cat Bounce" Stock
2016-08-04,Bluebird Bio (BLUE) In A Perilous Reversal
2016-08-04,Bluebird Bio To Present At Wedbush PacGrow Healthcare Conference
2016-08-03,Bluebird Bio Reports Second Quarter 2016 Financial Results And Recent Operational Progress
2016-08-01,Bluebird Bio (BLUE) Weak On High Volume
2016-07-28,4 Stocks to Play In Today's Market
2016-07-27,Bluebird Bio (BLUE) Marked As A Barbarian At The Gate
2016-07-22,Insider Trading Alert - AA, BLUE And VLGEA Traded By Insiders
2016-07-19,Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development Pact
2016-07-18,Bluebird Bio Presents MegaTAL Genome Editing Data At American Society Of Hematology (ASH) Workshop On Genome Editing
2016-07-07,Juno Patient Deaths Crash Cancer-Killing CAR-T Party
2016-07-01,Biotech Stock Mailbag: Mid-Year Assessment, Where We Go From Here
2016-06-27,A Biotech Stock Turnaround Requires an Alzheimer's Drug Miracle
2016-06-18,These 5 Stocks Could Be Toxic to Your Portfolio
2016-06-10,Global Blood Shows Extended, Safe Treatment Effect for Sickle Cell Disease Drug
2016-06-06,Bluebird Bio (BLUE) Is Today's Dead Cat Bounce Stock
2016-06-03,Stock To Watch: Bluebird Bio (BLUE) In Perilous Reversal
2016-05-23,Bluebird Bio To Present At Goldman Sachs 37th Annual Healthcare Conference
2016-05-13,Bluebird Bio (BLUE) Showing Signs Of A Dead Cat Bounce Today
2016-05-12,Mast Sickle Cell Drug Seeks to Defy Long Odds Like Leicester City
2016-05-10,Trade-Ideas: Bluebird Bio (BLUE) Is Today's "Perilous Reversal" Stock
2016-05-09,Bluebird Bio Presents Oncology And Gene Therapy Data At The ASGCT 19th Annual Meeting
2016-05-04,Bluebird Bio Reports First Quarter 2016 Financial Results And Recent Operational Progress
2016-04-27,Bluebird Bio To Present At Two Upcoming Investor Conferences
2016-04-20,Weak On High Volume: Bluebird Bio (BLUE)
2016-04-20,Bluebird Bio Reports Interim Clinical Data From Starbeam Study Of Lenti-D™ At AAN 2016 Annual Meeting
2016-04-20,Bluebird Bio Gene Therapy Shows Early Promise in Fatal Childhood Brain Disease
2016-04-18,Bluebird Bio To Present Immuno-Oncology And Gene Therapy Data At The ASGCT 19th Annual Meeting
2016-03-10,Bluebird Bio (BLUE) Is Today's Dead Cat Bounce Stock
2016-03-09,Today's Weak On High Volume Stock: Bluebird Bio (BLUE)
2016-03-03,Bluebird Bio To Present Clinical Data On Lenti-D In CALD In Plenary Session At AAN 2016 Annual Meeting
2016-03-02,Bluebird Bio To Present At Three Upcoming Investor Conferences
2016-02-26,Bluebird Bio (BLUE) Is Today's Dead Cat Bounce Stock
2016-02-25,Bluebird Bio Announces Transition Of Chief Financial Officer
2016-02-24,Bluebird Bio Reports Fourth Quarter And Full Year 2015 Financial Results And Recent Operational Progress
2016-02-17,Bluebird Bio Announces First Patient Treated With Bb2121 In CRB-401 Phase 1 Study In Patients With Relapsed/Refractory Multiple Myeloma
2016-02-02,Perilous Reversal Watch: Bluebird Bio (BLUE)
2016-01-29,Trade-Ideas: Bluebird Bio (BLUE) Is Today's "Dead Cat Bounce" Stock
2016-01-20,Commit To Buy bluebird bio At $22.50, Earn 20.4% Using Options
2016-01-13,bluebird bio (BLUE) Showing Signs of Perilous Reversal Today
2016-01-12,Bluebird Bio (BLUE) Is Today's Dead Cat Bounce Stock
2016-01-11,A Lack of News and Buzz at 'JPM16' Sinks Biotech Stocks
2016-01-11,Water-Logged And Getting Wetter Stock Of The Day: Bluebird Bio (BLUE)
2016-01-09,2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
2016-01-05,Bluebird Bio To Present At The 34th Annual J.P. Morgan Healthcare Conference
2016-01-01,Feuerstein's Heroes and Zeroes of Biotech Investing in 2015
2015-12-08,2 'Rules of the Road' for Biotech Investing
2015-12-07,Stocks Slump as Oil Closes at Lowest Since 2009
2015-12-07,Bluebird Bio Crashes After ASH Meeting Followed By Downgrades
2015-12-07,Midday Report: Keurig Deal Boosts Peers; Energy Stocks Slump
2015-12-07,Stocks Plummet as Crude Oil Nears $38
2015-12-07,Bluebird Bio (BLUE) Stock Tanks Following Analyst Downgrade
2015-12-07,Stock Futures Turn Mixed as Keurig Jumps, Chipotle Slumps
2015-12-07,Analysts' Actions -- Big Lots, Bluebird Bio, Eli Lilly, Match Group and More
2015-12-07,Bluebird Bio (BLUE): Heavy Pre-Market Activity
2015-12-07,Investors Remain Skeptical about Bluebird Gene Therapy for Blood Disease
2015-12-06,Bluebird Bio Presents Pre-Clinical And Manufacturing Data From CAR T Oncology Programs At ASH Annual Meeting
2015-12-06,Bluebird Sickle Cell Gene Therapy Falls Short of High Expectations
2015-12-06,Bluebird Bio Reports New Beta-thalassemia Major And Severe Sickle Cell Disease Data From HGB-205 And HGB-206 Studies Of LentiGlobin® At ASH Annual Meeting
2015-12-05,Bluebird, Celgene See Promise in T Cell Therapy for Multiple Myeloma
2015-12-05,Bluebird Bio Reports New Beta-thalassemia Major Data From Northstar Study Of LentiGlobin® At ASH Annual Meeting
2015-12-03,Bluebird Bio And ViroMed Enter Into License Agreement For Novel Antibodies To Develop Chimeric Antigen Receptor T Cell Therapy
2015-12-02,Bluebird Bio (BLUE) Marked As A Dead Cat Bounce Stock
2015-12-01,Jim Cramer's 'Mad Money' Recap: Stocks Gain When Analysts Curb Negativity
2015-11-25,Bluebird Bio Announces Participation In 27th Annual Piper Jaffray Healthcare Conference
2015-11-22,Goldman Sachs Says These 12 Small-Cap Stocks Are Worth Buying
2015-11-21,Clovis Blowup Conjures Bad Biotech Memories of ImClone Darkness
2015-11-19,Perilous Reversal Stock: Bluebird Bio (BLUE)
2015-11-18,Goldman Sees Bluebird Shares Doubling On 'One-Shot' Gene Therapy
2015-11-18,Today's Pre-Market Trading Very Positive For Bluebird Bio (BLUE)
2015-11-13,Biotech Stock Mailbag: Relypsa, Sophiris, Bluebird, Zafgen, NW Bio
2015-11-06,Bluebird Bio (BLUE) Marked As A Dead Cat Bounce Stock
2015-11-05,Bluebird Bio (BLUE): Heavy Pre-Market Activity
2015-11-05,Bluebird Gene Therapy Narrative Shift: 'Cure' May Elude Some Patients
2015-11-05,Bluebird Bio To Present LentiGlobin® BB305 Clinical Data And Bb2121 Preclinical Data At Annual Meeting Of The American Society Of Hematology
2015-11-04,Bluebird Bio Reports Third Quarter 2015 Financial Results And Recent Operational Progress
2015-11-04,Bluebird Bio Announces Participation In 24th Annual Credit Suisse Healthcare Conference
2015-10-23,Trade-Ideas: Bluebird Bio (BLUE) Is Today's Strong On High Relative Volume Stock
2015-10-19,Bluebird Shares Plunge on Waning Effect of Old Gene Therapy
2015-10-19,Bluebird Bio (BLUE) Showing Signs Of Being Water-Logged And Getting Wetter
2015-10-19,Bluebird Bio Announces Presentation At Cooley's Anemia Foundation Symposium
2015-10-16,Trade-Ideas: Bluebird Bio (BLUE) Is Today's Strong On High Relative Volume Stock
2015-10-16,Biotech Stock Mailbag: New Sarepta Risk, Zafgen Patient Death, Bluebird Gene Therapy Update
2015-10-07,Jim Cramer -- Microsoft, General Mills, WhiteWave Are Buying Opportunities
2015-10-07,Jim Cramer Bullish on Microsoft, Likes General Mills and WhiteWave
2015-10-05,Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector
2015-10-05,Trade-Ideas: Bluebird Bio (BLUE) Is Today's Pre-Market Leader Stock
2015-10-05,Analysts' Actions -- Twitter, AutoZone, Tyco, Viacom
2015-10-02,5 Stocks Poised for Breakouts
2015-09-29,Strong On High Volume: Bluebird Bio (BLUE)
2015-09-29,Alexandria Real Estate Equities, Inc. Announces 10-Year 253,000 RSF Full-Building Build-to-Suit Lease At 60 Binney Street For Bluebird Bio For Its New Office/Laboratory Headquarters In The Heart Of Kendall Square In Cambridge, MA
2015-09-25,bluebird bio is Now Oversold
2015-09-25,Biotech Stock Mailbag: Rebounding From Hillary's Drug Tweet; Global Blood Weighs on Bluebird
2015-09-24,Bluebird Bio Announces Participation In Leerink Partners Immuno-Oncology Roundtable
2015-09-21,Bluebird Bio (BLUE) Is Water-Logged And Getting Wetter Today
2015-09-11,Bluebird Bio Announces Participation At Morgan Stanley Global Healthcare Conference
2015-09-09,Perilous Reversal Watch: Bluebird Bio (BLUE)
2015-09-04,2 Issues Keeping Buyers on the Sidelines Today
2015-09-01,The Numbers Behind Biotech's Horrible, No Good, Awful August
2015-08-26,Biotech Selloff Has No Effect on Cellectis Advances: CEO
2015-08-26,Biotech Selloff Does Not Dim Immunotherapy Advances Says Cellectis CEO
2015-08-21,Biotech Stock Mailbag: Celldex, Bluebird, Kite, Inovio
2015-08-19,Biotech Stocks Get Burned This Summer, but Fall Might Bring Relief
2015-08-12,Bluebird, Pacira Pharmaceuticals Excite Life Science Investors
2015-08-12,Bluebird, Pacira Pharmaceuticals Gain Steam in Burgeoning Life Science Space
2015-08-10,BLUE, TEVA And AMGN, 3 Drugs Stocks Pushing The Industry Lower
2015-08-07,Water-Logged And Getting Wetter: Bluebird Bio (BLUE)
2015-08-06,Bluebird Bio Reports Second Quarter 2015 Financial Results And Recent Operational Progress
2015-08-05,Trade-Ideas: Bluebird Bio (BLUE) Is Today's Post-Market Leader Stock
2015-08-05,Bluebird Bio Announces Participation At The 2015 Wedbush PacGrow Healthcare Conference
2015-07-27,Biogen's Possible Takeout Targets and Other Key Questions After Blow-Up
2015-07-02,Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point
2015-07-01,Today's Perilous Reversal Stock: Bluebird Bio (BLUE)
2015-06-30,Today's Top Performers In Health Care
2015-06-30,Celgene on My Shopping List for a Pullback
2015-06-29,Celgene is Desperate or Insane to Pay Ultra-High Premium for Juno Partnership
2015-06-29,Trade-Ideas: Bluebird Bio (BLUE) Is Today's Post-Market Leader Stock
2015-06-23,Bluebird Bio Announces Pricing Of Public Offering Of Common Stock
2015-06-23,Bluebird Bio Announces Proposed Public Offering Of Common Stock
2015-06-19,Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!
2015-06-19,'Mad Money' Lightning Round: Buy, Buy, Buy Citigroup
2015-06-18,Jim Cramer's 'Mad Money' Recap: Here's Why We Had a Rally Today
2015-06-16,Avalanche Fails Common-Sense Test, Kicked Out of Gene Therapy Credibility Club
2015-06-15,Philip Gregory, D. Phil., Joins Bluebird Bio As Chief Scientific Officer
